Abstract
Introduction
Abdominal imaging is often performed after pancreatic cancer resection. We attempted to quantify the volume and estimate the cost of complex imaging after pancreatectomy nationwide, and to determine whether their frequent use confers benefit.
Methods
Patients with pancreatic adenocarcinoma who underwent resection were identified in Surveillance, Epidemiology and End Results–Medicare (1991–2005). Claims for abdominal imaging ≤5 years after resection were analyzed. Patients receiving annual CT scans were identified. Univariate and multivariate analyses were performed. To assess frequency of annual CT scanning in patients with superior survival, the top decile was further analyzed.
Results
Eleven thousand eight hundred fifty studies were performed on 2,217 patients. Ten thousand five hundred forty-two (89%) were CT scans. The median number of scans doubled from three in 1991 to six in 2005 (p < 0.0001). Among patients with sufficient survival to allow for analysis, 51.3% received annual CT scans, while only 32.4% of top-performing patients received annual scans. Univariate analysis of the 10% of patients with superior survival did not reveal any significant benefit associated with annual imaging.
Conclusion
Utilization of complex imaging after pancreatic cancer resection has increased substantially among Medicare beneficiaries, driven primarily by an increasing number of CT scans. Our study demonstrated no significant survival benefit among patients who received scans on a routine basis.
Similar content being viewed by others
References
Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. May 2006;17(4):403–409.
Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. Aug 2007;246(2):173–180.
Carroll JE, Smith JK, Simons JP, et al. (2010) Redefining mortality after pancreatic cancer resection. J Gastrointest Surg 14(11):1701–1708.
Riall TS, Nealon WH, Goodwin JS, et al. Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg. Nov 2006;10(9):1212–1223; discussion 1223–1214.
Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. Mar 2008;247(3):456–462.
Simons JP, Shah SA, Ng SC, Whalen GF, Tseng JF. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. Oct 2009;13(10):1798–1805.
Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA. Apr 28 2010;303(16):1625–1631.
Institute NC. Brief Description of SEER-Medicare Database. 2009; http://healthservices.cancer.gov/seermedicare/overview/. Accessed 8/7/10, 2010.
Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. Aug 2002;40(8 Suppl):IV-55-61.
Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008;8:12.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. Jun 1992;45(6):613–619.
Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. Dec 2000;53(12):1258–1267.
Centers for Medicare and Medicaid Services (Services CfMM). Physician Fee Schedule. 2011; https://http://www.cms.gov/PhysicianFeeSched/. Accessed 4/1/2011, 2011.
Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association. June 1958;53(282):457–481.
Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical care. Aug 2002;40(8 Suppl):IV-104-117.
Simons JP, Ng SC, McDade TP, Zhou Z, Earle CC, Tseng JF. Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices. Cancer. Apr 1 2010;116(7):1681–1690.
Sources of Funding
This work was supported by American Cancer Society MSRG-10-003-01-CPHPS, a Howard Hughes Early Career Award, NIH 1 UL1RR031982, and by the Pancreatic Cancer Alliance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Witkowski, E.R., Smith, J.K., Ragulin-Coyne, E. et al. Is It Worth Looking? Abdominal Imaging After Pancreatic Cancer Resection: a National Study. J Gastrointest Surg 16, 121–128 (2012). https://doi.org/10.1007/s11605-011-1699-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-011-1699-z